SCHEMBL17166114

SCHEMBL17166114

CCCC(=O)Nc1ccc(-n2nc(C)cc2-c2ccc3ccc4ccccc4c3c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 3/20 0.55
PTGS2 P35354 3/20 0.50
ALDH1A1 P00352 6/20 0.47
HPGD P15428 5/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RECQL P46063 1/20 0.47
TP53 P04637 3/20 0.45
MDM2 Q00987 1/20 0.42
CA9 Q16790 1/20 0.42
MAPT P10636 2/20 0.42
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 2/20 0.41
NTRK1 P04629 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16200829 0.93 PDPK1 (0.59) PDPK1PTGS2ALDH1A1HPGDCYP1A2
SCHEMBL14825410 0.88 PDPK1 (0.62) PDPK1PTGS2ALDH1A1HPGDCYP1A2
SCHEMBL12054881 0.85 PDPK1 (0.75) PDPK1PTGS2ALDH1A1HPGDCYP1A2
SCHEMBL15000396 0.84 PDPK1 (0.55) PDPK1PTGS2ALDH1A1HPGDCYP1A2
SCHEMBL16196163 0.80 CA9 (0.59) PDPK1PTGS2CA9
SCHEMBL16195916 0.80 PDPK1 (0.56) PDPK1PTGS2ALDH1A1CA9
SCHEMBL2602397 0.79 PDPK1 (0.62) PDPK1PTGS2ALDH1A1HPGDCA9
SCHEMBL2719679 0.79 PTGS2 (0.65) PDPK1PTGS2TP53CA9NPC1
SCHEMBL16196304 0.79 PDPK1 (0.80) PDPK1PTGS2TP53MAPTSMN1; SMN2
SCHEMBL15346617 0.79 ALDH1A1 (0.70) PDPK1PTGS2ALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9156790-B2 Anticancer P21-activated kinase inhibitors OHIO STATE INNOVATION FOUNDATION (US) 2015-10-13 US disclosed